Public disclosure of inside information according to article 17 MAR
Leverkusen (pta006/29.12.2021/10:20) - Leverkusen, Germany, December 29, 2021 - Today, Biofrontera AG (ISIN: DE0006046113), was informed by Biofrontera Inc. (Nasdaq: BFRI) that the total amount of BFRI shares outstanding has increased due to exercises of previously issued warrants. As a result, Biofrontera AG’s shareholding in Biofrontera Inc. of 8,000,000 shares now represents approximately 47 % of the currently outstanding shares.
Thus, after legal review, Biofrontera Inc. is no longer considered a subsidiary of Biofrontera AG according to § 290 HGB.
Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen
Tel: +49 (0214) 87 63 2 0, Fax: +49 (0214) 87 63 290
emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: Nasdaq